1. Communicate potential paradigmatic changes in management and assessment of multiple myeloma

2. Identify novel pathophysiologic mechanism in catastrophic antiphospholipid syndrome

3. Discuss cost-effectiveness considerations with novel oncolytics, using Hodgkin lymphoma as a model

4. Identify and discuss stand-out abstracts from the American Society of Hematology annual meeting 2019

5. Describe rapidly evolving developments in myeloid diseases, including therapeutics and practice recommendations

6. Describe recent advances in immunotherapy for the treatment of mantle cell lymphoma and acute lymphoblastic leukemia

7. Evaluate monitoring of coagulation testing in patients on heparin and implications on clinical management